Table 2 Iron replacement treatment episodes preceded and/or followed by a biological assessment [transferrin saturation index and/or serum ferritin]—from French healthcare coverage databases (EGB) 2006–2013.
Assessment before treatment | Assessment after treatment | Assessment before AND after treatment | ||||
|---|---|---|---|---|---|---|
n | (%) | n | (%) | n | (%) | |
All—total sample (n = 166 015 episodes) | ||||||
Transferrin saturation (TSAT) | 1677 | (1.0) | 863 | (0,5) | ||
Ferritin | 56,081 | (33.8) | 24,952 | (15.0) | ||
TSAT or ferritin | 57,510 | (34.6) | 25,654 | (15.5) | 12,161 | (7.3) |
Oral iron replacement therapy—total sample (n = 165 100 episodes) | ||||||
TSAT | 1631 | (1.0) | 823 | (0.5) | ||
Ferritin | 55,472 | (33.6) | 24,398 | (14.8) | ||
TSAT or ferritin | 56,890 | (34.5) | 25,087 | (15.2) | 11,661 | (7.1) |
Iron replacement therapy—patients without chronic diseases (n = 126 755 episodes) | ||||||
TSAT | 978 | (0.8) | 433 | (0.3) | ||
Ferritin | 31,531 | (24.9) | 14,081 | (11.1) | ||
TSAT or ferritin | 43,881 | (34.6) | 16,607 | (13.1) | 7,774 | 6.1 |
Iron replacement therapy—patients with chronic diseases (n = 29 171 episodes) | ||||||
TSAT | 544 | (1.9) | 351 | (1.2) | ||
Ferritin | 9,309 | (31.9) | 6,685 | (22.9) | ||
TSAT or ferritin | 10,107 | (34.6) | 6,948 | (23.8) | 3,438 | (11.8) |
